Sarfaraz Sami, Adhami Vaqar M, Syed Deeba N, Afaq Farrukh, Mukhtar Hasan
Chemoprevention Program, Paul P. Carbone Comprehensive Cancer Center and Department of Dermatology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin 53706, USA.
Cancer Res. 2008 Jan 15;68(2):339-42. doi: 10.1158/0008-5472.CAN-07-2785.
Cannabinoids are a class of pharmacologic compounds that offer potential applications as antitumor drugs, based on the ability of some members of this class to limit inflammation, cell proliferation, and cell survival. In particular, emerging evidence suggests that agonists of cannabinoid receptors expressed by tumor cells may offer a novel strategy to treat cancer. Here, we review recent work that raises interest in the development and exploration of potent, nontoxic, and nonhabit forming cannabinoids for cancer therapy.
大麻素是一类药理化合物,基于该类化合物中的一些成员具有限制炎症、细胞增殖和细胞存活的能力,它们有望作为抗肿瘤药物应用。特别是,新出现的证据表明,肿瘤细胞表达的大麻素受体激动剂可能为癌症治疗提供一种新策略。在此,我们综述了最近的研究工作,这些工作引发了人们对开发和探索用于癌症治疗的强效、无毒且无成瘾性的大麻素的兴趣。